Cargando…

Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers and is forecasted to become the second most common cause of cancer-related deaths by 2030. Its therapy has proven extremely difficult and, consequently, there is an urgent need for novel therapeutic strategies fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lottini, Tiziano, Duranti, Claudia, Iorio, Jessica, Martinelli, Michele, Colasurdo, Rossella, D’Alessandro, Franco Nicolás, Buonamici, Matteo, Coppola, Stefano, Devescovi, Valentina, La Vaccara, Vincenzo, Coppola, Alessandro, Coppola, Roberto, Lastraioli, Elena, Arcangeli, Annarosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093586/ https://www.ncbi.nlm.nih.gov/pubmed/37046674 http://dx.doi.org/10.3390/cancers15072013

Ejemplares similares

hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers
por: Lastraioli, Elena, et al.
Publicado: (2015)

Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas
por: Iorio, Jessica, et al.
Publicado: (2022)

Integrins regulate hERG1 dynamics by girdin-dependent Gαi3: signaling and modeling in cancer cells
por: Duranti, Claudia, et al.
Publicado: (2023)

Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K
por: Petroni, Giulia, et al.
Publicado: (2020)

Correction: Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K
por: Petroni, Giulia, et al.
Publicado: (2020)

The Interaction between hERG1 and β1 Integrins Modulates hERG1 Current in Different Pathological Cell Models
por: Chioccioli Altadonna, Ginevra, et al.
Publicado: (2022)

The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples
por: Lastraioli, Elena, et al.
Publicado: (2019)

Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging
por: Duranti, Claudia, et al.
Publicado: (2018)

hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients()
por: Iorio, Jessica, et al.
Publicado: (2020)

Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex
por: Santini, Lorenzo, et al.
Publicado: (2023)

K(V)11.1 Potassium Channel and the Na(+)/H(+) Antiporter NHE1 Modulate Adhesion-Dependent Intracellular pH in Colorectal Cancer Cells
por: Iorio, Jessica, et al.
Publicado: (2020)

hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance
por: Lastraioli, Elena, et al.
Publicado: (2016)

Characterization of hERG1 channel role in mouse colorectal carcinogenesis
por: Fiore, Antonella, et al.
Publicado: (2013)

hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer
por: Iorio, Jessica, et al.
Publicado: (2018)

hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma
por: Lastraioli, E, et al.
Publicado: (2015)

hERG1 Potassium Channel Expression in Colorectal Adenomas: Comparison with Other Preneoplastic Lesions of the Gastrointestinal Tract
por: Lastraioli, Elena, et al.
Publicado: (2022)

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy
por: Muratori, Leonardo, et al.
Publicado: (2016)

Corrigendum to “Transcriptomic data of Bevacizumab-adapted colorectal adenocarcinoma cells HCT-116” [Data In Brief, Volume 48, (Available online 17 March 2023) 1-9/Article 109069]
por: Sala, Cesare, et al.
Publicado: (2023)

Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses
por: Lottini, Tiziano, et al.
Publicado: (2021)

hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
por: Crociani, Olivia, et al.
Publicado: (2013)

Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway
por: Fortunato, Pina, et al.
Publicado: (2010)

Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups
por: Pillozzi, S, et al.
Publicado: (2014)

The electric heart of hERG
por: Islas, León D.
Publicado: (2013)

An Update on the Structure of hERG
por: Butler, Andrew, et al.
Publicado: (2020)

Expression of the ether-a-gò-gò-related gene 1 channel during B and T lymphocyte development: role in BCR and TCR signaling
por: Sala, Cesare, et al.
Publicado: (2023)

High throughput clone screening on overexpressed hERG1 and Kv1.3 potassium channels using ion channel reader (ICR) label free technology
por: Montalbano, Alberto, et al.
Publicado: (2023)

CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
por: Coppola, Alessandro, et al.
Publicado: (2021)

The N-linker region of hERG1a upregulates hERG1b potassium channels
por: Johnson, Ashley A., et al.
Publicado: (2022)

hERG1a N-terminal eag domain–containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: A possible mechanism for long QT syndrome
por: Trudeau, Matthew C., et al.
Publicado: (2011)

Electrophysiological characterization of the modified hERG(T) potassium channel used to obtain the first cryo‐EM hERG structure
por: Zhang, Yihong, et al.
Publicado: (2020)

Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going
por: Coppola, Alessandro, et al.
Publicado: (2023)

Preoperative systemic inflammatory biomarkers and postoperative day 1 drain amylase value predict grade C pancreatic fistula after pancreaticoduodenectomy
por: Caputo, Damiano, et al.
Publicado: (2020)

Right hepatic artery anomalies in pancreatoduodenectomy—a risk for arterial resection but not for postoperative outcomes
por: La Vaccara, Vincenzo, et al.
Publicado: (2023)

An Insight into the Potassium Currents of hERG and Their Simulation
por: Guidelli, Rolando
Publicado: (2023)

Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles
por: Digiacomo, Luca, et al.
Publicado: (2021)

Stereoselective Blockage of Quinidine and Quinine in the hERG Channel and the Effect of Their Rescue Potency on Drug-Induced hERG Trafficking Defect
por: Yan, Meng, et al.
Publicado: (2016)

The Activity of K(V)11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells
por: Manoli, Sagar, et al.
Publicado: (2019)

Ensemble of structure and ligand-based classification models for hERG liability profiling
por: Vittorio, Serena, et al.
Publicado: (2023)

Validations of new cut-offs for surgical drains management and use of computerized tomography scan after pancreatoduodenectomy: The DALCUT trial
por: Caputo, Damiano, et al.
Publicado: (2022)

Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives
por: Coppola, Alessandro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o3c79jvfmqcncjrqhviu1e6blh